ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
US Tech 100
20,762.73
1.73%
Dow Jones
42,732.13
0.80%
Brent Oil
76.495
0.00%
Bitcoin
98,289.40
0.08%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Benchmark Holdings Plc (BMK) Quote

Benchmark Holdings Plc

Benchmark Holdings Plc (BMK)

MacDonald Mines Exploration Ltd
30.70
-0.75
(-2.38%)
Closed January 05 11:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
30.70
Bid
30.50
Ask
30.90
Volume
172,571
30.50 Day's Range 33.00
30.00 52 Week Range 48.00
Market Cap
227.116M
Previous Close
31.45
Open
33.00
Last Trade
75000
@
31.254
(O)
Last Trade Time
Financial Volume
54,316p
VWAP
31.4748
Average Volume (3m)
136,307
Shares Outstanding
739,790,997
Dividend Yield
-
PE Ratio
-9.74
Earnings Per Share (EPS)
-0.03
Revenue
169.74M
Net Profit
-23.15M

About Benchmark Holdings Plc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
benchmarkplc.com
Headquarters
Sheffield, Gbr
Founded
-
Benchmark Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker BMK. The last closing price for Benchmark was 31.45p. Over the last year, Benchmark shares have traded in a share price range of 30.00p to 48.00p.

Benchmark currently has 739,790,997 shares outstanding. The market capitalization of Benchmark is £232.66 million. Benchmark has a price to earnings ratio (PE ratio) of -9.74.

Ask ADVFN Intelligence (AI)

BMK Latest News

More News

Benchmark Holdings PLC Total Voting Rights

Benchmark Holdings PLC 31 December 2024   31 December 2024   Benchmark Holdings plc ("Benchmark" or "the Company") Total Voting Rights In accordance with the FCA's Disclosure and Transparency...

December 31 2024
RNS Regulatory News

Benchmark Holdings PLC Result of General Meeting

Benchmark Holdings PLC 16 December 2024   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD...

December 16 2024
RNS Regulatory News

Benchmark Holdings annual loss widens; sets returns from Genetics sale

Benchmark Holdings PLC on Thursday said it is in a position to realise the potential of its two remaining business ar ...

December 12 2024
Alliance News

Benchmark Holdings PLC Chairman Appointment

Benchmark Holdings PLC 12 December 2024     The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

December 12 2024
RNS Regulatory News

Benchmark Holdings PLC Full Year Results

Benchmark Holdings PLC 12 December 2024   12 December 2024   Benchmark Holdings plc   ("Benchmark", the "Company" or the "Group")   Full Year Results for the Financial Year ended 30 September...

December 12 2024
RNS Regulatory News

Benchmark Holdings PLC Total Voting Rights

Benchmark Holdings PLC 29 November 2024   29 November 2024   Benchmark Holdings plc ("Benchmark" or "the Company") Total Voting Rights In accordance with the FCA's Disclosure and Transparency...

November 29 2024
RNS Regulatory News

Numis Securities Limited Form 8.5 (EPT/RI) - Benchmark Holdings plc

Numis Securities Limited 27 November 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

November 27 2024
RNS Regulatory News

Benchmark Holdings PLC Notice of GM

Benchmark Holdings PLC 26 November 2024   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD...

November 26 2024
RNS Regulatory News

Janus Henderson Investors Form 8.3 - Benchmark Holdings plc

Janus Henderson Investors 26 November 2024    FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule...

November 26 2024
RNS Regulatory News

Numis Securities Limited Form 8.5 (EPT/RI) - Benchmark Holdings plc

Numis Securities Limited 26 November 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...

November 26 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3.6-10.495626822234.334.33012406031.92400185DE
4-5.3-14.722222222236373012108133.333366DE
12-10.15-24.84700122440.85433013630736.88661571DE
26-9.9-24.384236453240.643308693037.73441042DE
52-4.8-13.521126760635.548308457740.20776577DE
156-27.3-47.068965517258593021856644.38385951DE
260-13.3-30.2272727273446726.538560043.80437809DE

BMK - Frequently Asked Questions (FAQ)

What is the current Benchmark share price?
The current share price of Benchmark is 30.70p
How many Benchmark shares are in issue?
Benchmark has 739,790,997 shares in issue
What is the market cap of Benchmark?
The market capitalisation of Benchmark is GBP 232.66M
What is the 1 year trading range for Benchmark share price?
Benchmark has traded in the range of 30.00p to 48.00p during the past year
What is the PE ratio of Benchmark?
The price to earnings ratio of Benchmark is -9.74
What is the cash to sales ratio of Benchmark?
The cash to sales ratio of Benchmark is 1.33
What is the reporting currency for Benchmark?
Benchmark reports financial results in GBP
What is the latest annual turnover for Benchmark?
The latest annual turnover of Benchmark is GBP 169.74M
What is the latest annual profit for Benchmark?
The latest annual profit of Benchmark is GBP -23.15M
What is the registered address of Benchmark?
The registered address for Benchmark is BENCHMARK HOUSE, 8 SMITHY WOOD DRIVE, SHEFFIELD, S35 1QN
What is the Benchmark website address?
The website address for Benchmark is benchmarkplc.com
Which industry sector does Benchmark operate in?
Benchmark operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
HyGro HyGro 54 seconds ago
NWBO share price dropped 58% i 52 weeks -- That means that longs are SELLING as they don't have confidence in the future of the company. No cash, vulture investors diluting shareholders, no real commercial prospects (UK is poor oncology market), and no U.S. potential.
NWBO
Riley4 Riley4 2 minutes ago
Dang, that kills it, great response
NWBO
ace65 ace65 5 minutes ago
Last couple of days here were good..Relax.
PPCB
Mr. Bill Mr. Bill 10 minutes ago
https://www.medicinenet.com/what_are_blood_oxygen_levels/article.htm
devil dog 96 devil dog 96 11 minutes ago
Tell everyone why you think they never took the 39 million shares off restriction if they need shares to dump? Why have they not taken 1 share off restriction since early 2021 if they need shares to dump?? Why would they issue new shares that will be unregistered and also have to wait a year before
ATMH
CrossFireTrader CrossFireTrader 11 minutes ago
Page 22 of 26, and If say I'm Bullish that'll set 280e off, and I'll  be accused of pumping our little lottery ticket. I'm here for the long haul. I'm not here to sell at 0.016 or 0.02 or 0.03 or whatever his new price is. He actually likes GDVM a lot more than he lets on. Since you seem to be somew
GDVM
Mr. Bill Mr. Bill 15 minutes ago
https://measuringmyhealth.com/what-is-a-normal-pi-on-a-pulse-oximeter/
georgejjl georgejjl 15 minutes ago
That is WRONG. The current standard of care is donepezil (Aricept) and memantine, etc.

MAB's still are an extremely small number of treatments for Alzheimer's in the USA and worldwide.

Good luck and GOD bless,
AVXL
axelvento axelvento 35 minutes ago
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 38 minutes ago
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 39 minutes ago
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 39 minutes ago
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 40 minutes ago
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 41 minutes ago
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 42 minutes ago
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 43 minutes ago
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 44 minutes ago
Probably
AVXL
HokieHead HokieHead 46 minutes ago
Wrong..
TWOH
HokieHead HokieHead 47 minutes ago
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 48 minutes ago
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 50 minutes ago
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 50 minutes ago
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 51 minutes ago
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX

Your Recent History

LSE
BMK
Benchmark
NASDAQ
FCVT
First Trust SSI Strategi...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads